Patents by Inventor Helle Weibel

Helle Weibel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ipamorelin Diacetate Injection and Infusion Solutions
    Publication number: 20100317581
    Abstract: Injection and infusion solutions of ipamorelin, having the following composition: a) ipamorelin solubilized by approximately two molar equivalents of acetic acid (ipamorelin diacetate), in an amount of from 0.001 to 20%, based on the weight of the free base of ipamorelin; b) a molar excess of acid, preferably acetic acid, in an amount sufficient to give a pH of at least 3 and less than 7; c) optionally from 0.1 to 30% of one or more formulation aids; and d) water q.s. to 100%; all percentages based on the total weight of the solution.
    Type: Application
    Filed: June 8, 2010
    Publication date: December 16, 2010
    Applicant: Helsinn Therapeutics (U.S.), Inc.
    Inventors: Silvina Garcia Rubio, Daniel E. Beidler, Helle Weibel, Riccardo Braglia
  • Pharmaceutical composition and the process for its preparation
    Patent number: 7439248
    Abstract: The present invention provides a new stable pharmaceutical composition containing 5-[[4-[3-Methyl-4-oxo-3,4-dihydro-2-quinazolinyl]methoxy]phenyl-methyl]thiadiazolidine-2,4-dione as active ingredient.
    Type: Grant
    Filed: November 30, 1999
    Date of Patent: October 21, 2008
    Assignees: Dr. Reddy's Laboratories Limited, Dr. Reddy's Laboratories, Inc.
    Inventors: Helle Weibel, Thyge Borup Hjorth
  • Pharmaceutical composition and the process for its preparation
    Publication number: 20040091523
    Abstract: The present invention provides a new stable pharmaceutical composition containing 5-[[4-[3-methyl-4-oxo-3,4-dihydro-2-quinazolinyl]methoxy]phenylmethyl]thiazolidine-2,4-dione as active ingredient.
    Type: Application
    Filed: October 31, 2003
    Publication date: May 13, 2004
    Inventors: Helle Weibel, Thyge Borup Hjorth
  • Pharmaceutical composition and the process for its preparation
    Patent number: 6710050
    Abstract: The present invention provides a new stable pharmaceutical composition containing 5-[[4-[3-methyl-4-oxo-3,4-dihydro-2-quinazolinyl]methoxy]phenylmethyl]thiazolidine-2,4-dione as active ingredient.
    Type: Grant
    Filed: May 23, 2001
    Date of Patent: March 23, 2004
    Assignees: Novo Nordisk A/S, Dr. Reddy's Research Foundation
    Inventors: Helle Weibel, Thyge Borup Hjorth
  • Pharmaceutical composition and the process for its preparation
    Publication number: 20020010187
    Abstract: The present invention provides a new stable pharmaceutical composition containing 5-[[4-[3 -methyl-4-oxo-3,4-dihydro-2-quinazolinyl]methoxy]phenylmethyl]thiazolidine-2,4-dione as active ingredient.
    Type: Application
    Filed: May 23, 2001
    Publication date: January 24, 2002
    Inventors: Helle Weibel, Thyge Borup Hjorth
  • Transdermal delivery of 3,4-diarylchromans
    Patent number: 5935987
    Abstract: Therapeutically effective amounts of a 3,4-diarylchroman can be administered transdermally by incorporation of the 3,4-diarylchroman in a matrix or liquid reservoir patch suitable for transdermal delivery, which matrix or liquid reservoir patch optionally contains hydrophobic and/or hydrophilic vehicle(s).
    Type: Grant
    Filed: November 18, 1997
    Date of Patent: August 10, 1999
    Assignee: Novo Nordisk A/S
    Inventors: Svend Treppendahl, Klaus Snej Jensen, Scott E. McGraw, Helle Weibel
  • Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation
    Patent number: 5866590
    Abstract: The present invention provides a new stable pharmaceutical composition containing tiagabine hydrochloride as active ingredient.
    Type: Grant
    Filed: October 28, 1997
    Date of Patent: February 2, 1999
    Assignee: Novo Nordisk A/S
    Inventors: J.o slashed.rgen Ryhl Svensson, Lars Nygaard, Tina Meinertz Andersen, Helle Weibel, Thyge Borup Hjorth
  • Transdermal delivery of tiagabine
    Patent number: 5750140
    Abstract: A transdermal delivery system containing tiagabine or its pharmaceutically acceptable salts or esters is disclosed. The delivery system is useful in the treatment of epilepsy.
    Type: Grant
    Filed: May 12, 1995
    Date of Patent: May 12, 1998
    Assignee: Novo Nordisk A/S
    Inventors: Helle Weibel, Peter Bonne Eriksen